Company · CIK 0001509261 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Rezolute, Inc. · RZLT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 FForm 4 → | Sep 3, 4:42 pm EDT | Sunil Ratilal KarnawatChief Commercial Officer | 2,267 | $4.50 | $10,202 | 69,275 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 6:36 pm EDT | Brian Kenneth RobertsChief Medical Officer | 3,062 | $4.99 | $15,279 | 293,851 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 5:27 pm EDT | Nevan C ElamCEO, Director | 8,004 | $4.99 | $39,940 | 605,497 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 5:26 pm EDT | Daron EvansCFO | 3,062 | $4.99 | $15,279 | 411,400 | — | |
| Mar 8, 2017 PForm 4 → | Mar 15, 4:04 pm EDT | David F WelchDirector | 15,000 | $0.96 | $14,400 | 1,811,415 | +0.83% | plan? late |
| Mar 6, 2017 PForm 4 → | Mar 8, 3:48 pm EST | David F WelchDirector | 5,000 | $0.95 | $4,750 | 1,796,415 | +0.28% | plan? |
| Feb 10, 2017 PForm 4 → | Feb 17, 3:00 pm EST | David F WelchDirector | 5,000 | $0.99 | $4,950 | 28,100 | +21.6% | plan? late |
| Feb 7, 2017 PForm 4 → | Feb 13, 5:49 pm EST | David F WelchDirector | 13,100 | $0.9815 | $12,857 | 23,100 | +131% | plan? late |
| Feb 3, 2017 PForm 4 → | Feb 9, 4:21 pm EST | David F WelchDirector | 10,000 | $0.955 | $9,550 | 10,000 | — | plan? late |
| Jan 18, 2017 PForm 4 → | Jan 24, 7:52 pm EST | David F WelchDirector | 24,983 | $1.01 | $25,182 | 1,791,415 | +1.41% | plan? late |
| Jan 12, 2017 PForm 4 → | Jan 20, 2:45 pm EST | David F WelchDirector | 5,000 | $0.95 | $4,750 | 15,000 | +50.0% | plan? late |
| Jan 10, 2017 PForm 4 → | Jan 17, 5:02 pm EST | David F WelchDirector | 10,000 | $0.9263 | $9,263 | 10,000 | — | plan? late |
| Feb 9, 2015 SForm 4 → | Jan 11, 2016, 5:50 pm EST | Nevan C ElamChief Executive Officer, Director | 842,949 | — | — | 0 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2016 AForm 4 → | Jan 18, 2017, 3:28 pm EST | Hoyoung HuhChairman, Scientific Adv. Bd., Director | 4,000,000 | — | — | 4,000,000 | — | late |
| Oct 31, 2016 AForm 4 → | Jan 17, 2017, 5:02 pm EST | David F WelchDirector | 750,000 | — | — | 750,000 | — | late |
| Oct 31, 2016 AForm 4 → | Jan 13, 2017, 7:32 pm EST | Barry Michael ShermanDirector | 300,000 | — | — | 300,000 | — | late |
| Oct 31, 2016 AForm 4 → | Jan 13, 2017, 7:31 pm EST | Morgan FieldsChief Accounting Officer | 600,000 | — | — | 600,000 | — | late |
| Oct 31, 2016 AForm 4 → | Jan 13, 2017, 7:30 pm EST | Nevan C ElamChief Executive Officer, Director | 3,500,000 | — | — | 3,500,000 | — | late |
| Dec 10, 2015 PForm 4 → | Dec 21, 4:33 pm EST | David F WelchDirector | 256,410 | $1.95 | $500,000 | 256,410 | — | late |
| Feb 9, 2015 PSForm 4 → | Jan 11, 2016, 5:50 pm EST | Nevan C ElamChief Executive Officer, Director | 116,040 | $1.95 | $150,000 | 76,923 | — | late |